# Mortality Reduction in Septic Shock by Plasma Adsorption

> **NCT02357433** · NA · TERMINATED · sponsor: **Francisco Colomina Climent** · enrollment: 55 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DEVICE:** High Doses CPFA

## Key facts

- **NCT ID:** NCT02357433
- **Lead sponsor:** Francisco Colomina Climent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** Circumstances beyond the course of the trial have produced a change in the conditions of recruitment unacceptable to the ROMPA researchers
- **Last updated:** 2018-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357433, "Mortality Reduction in Septic Shock by Plasma Adsorption". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02357433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*